MacroGenics | MGNX - Cost Of Sales

Stock Price
1.81
Daily Change
0.11 6.47%
Monthly
0%
Yearly
-30.38%
Q1 Forecast
1.75

MacroGenics reported $44.3M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Amgen USD 1.79B 128M Dec/2025
AstraZeneca USD 2.8B 328M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Genmab DKK 57M 15M Jun/2025
Geron USD 1.04M 147K Sep/2025
Gilead Sciences USD 1.57B 68M Sep/2025
J&J USD 7.97B 689M Dec/2025
MacroGenics USD 44.3M 5.4M Sep/2025
Merck USD 3.32B 531M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Xencor USD 61.66M 50.95M Jun/2025